Table 1 Patient characteristics of patients referred to LH clinic for assessment for antiviral therapy of chronic hepatitis B
Patients with ultrasound abnormalities (n = 31) | Patient without ultrasound abnormalities (n = 80) | ||
|---|---|---|---|
Demographic | |||
Sex (M/F, %) | 25/6 (80.6%/19.4%) | 47/33 (58.7%/41.2%) | p = 0.0309 |
Age, years [IQR] | 35 [30–40] | 30 [28–36] | |
Signs/symptoms | |||
Abdominal swelling (%) | 19 (61.3%) | 5 (6.3%) | p < 0.0001 |
Abdominal pain (%) | 18 (58.1%) | 6 (7.5%) | p < 0.0001 |
Jaundice (%) | 7 (22.6%) | 8 (10.0%) | n.s. |
Nausea/Vomiting (%) | 11 (35.5%) | 7 (8.8%) | p = 0.0007 |
Laboratory results | |||
ALT (mean, 95% CI) | 70 [50–91] | 136 [57–214] | n.s. |
AST (mean, 95% CI) | 211 [117–305] | 95 [43–146] | p = 0.024 |
Bilitot (mean, 95% CI) | 3.6 [1.5–5.8] | 2.6 [1.0-4.2] | n.s. |
APRI# (mean, 95% CI) | 5.0 [1.4–8.5] | 1.6 [0.7–2.6] | p = 0.012 |
HBV Treatment | |||
Treated | 31 (100%) | 14 (17.5%) | p < 0.0001 |